[1]Bleyer AJ, Kmoch S. Tamm horsfall glycoprotein and uromodulin: it is all about the tubules![J]. Clin J Am Soc Nephrol, 2016, 11: 6-8. [2]Kraus D, Wanner C. Uromodulin in the bloodstream: old wine in a new wineskin[J]. J Am Soc Nephrol, 2017, 28: 1955-1957. [3]Wu TH, Li KJ, Yu CL, et al. Tamm-horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system[J]. Molecules, 2018, 23:200-214. [4]Nie M, Bal MS, Liu J, et al. Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6)[J]. J Biol Chem, 2018, 293: 16488-16502. [5]Krajcoviechova A, Marois-Blanchet FC, Troyanov S, et al. Uromodulin in a pathway between decreased renal urate excretion and albuminuria[J].Am J Hypertens, 2019, 32: 384-392. [6]Graham LA, Dominiczak AF, Ferreri NR. Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure[J]. Physiol Genomics, 2017, 49: 261-276. [7]Liu Y, Mo L, Goldfarb DS, et al. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein[J]. Am J Physiol Renal Physiol, 2010, 299: F469-F478. [8]Ghirotto S, Tassi F, Barbujani G, et al. The uromodulin gene locus shows evidence of pathogen adaptation through human evolution[J]. J Am Soc Nephrol, 2016, 27: 2983-2996. [9]Garimella PS, Jaber BL, Tighiouart H, et al. Association of preoperative urinary uromodulin with AKI after cardiac surgery[J]. Clin J Am Soc Nephrol, 2017, 12: 10-18. [10]Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders[J]. Nat Rev Nephrol, 2017, 13: 525-544. [11]Ayasreh N, Bullich G, Miquel R, et al. Autosomal dominant tubulointerstitial kidney disease: Clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1[J]. Am J Kidney Dis, 2018, 72: 411-418. [12]Bleyer AJ, Kidd K, Zivna M, et al. Autosomal dominant tubulointerstitial kidney disease[J]. Adv Chronic Kidney Dis, 2017, 24: 86-93. [13]Pattaro C, Teumer A, Gorski M, et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function[J]. Nat Commun, 2016, 7: 10023-10042. [14]Boger CA, Gorski M, Li M, et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD[J]. PLoS Genet, 2011, 7: e1002292. doi:10.1371/journal.pgen.1002292. [15]Kottgen A, Glazer NL, Dehghan A, et al. Multiple loci associated with indices of renal function and chronic kidney disease[J]. Nat Genet, 2009, 41: 712-717. [16]Leiherer A, Muendlein A, Saely CH, et al. The value of uromodulin as a new serum marker to predict decline in renal function[J]. J Hypertens, 2018, 36: 110-118. [17]Sjaarda J, Gerstein HC, Yusuf S, et al. Blood HER2 and uromodulin as causal mediators of CKD[J]. J Am Soc Nephrol, 2018, 29: 1326-1335. [18]Matafora V, Cuccurullo M, Beneduci A, et al. Early markers of Fabry disease revealed by proteomics[J]. Mol Biosyst, 2015, 11: 1543-1551. [19]Pruijm M, Ponte B, Ackermann D, et al. Associations of urinary uromodulin with clinical characteristics and markers of tubular function in the general population[J]. Clin J Am Soc Nephrol, 2016, 11: 70-80. [20]Steubl D, Block M, Herbst V, et al. Serum uromodulin predicts graft failure in renal transplant recipients[J]. Biomarkers, 2017, 22: 171-177. [21]Trevisani F, Larcher A, Cinque A, et al. The association of uromodulin genotype with renal cancer aggressiveness[J]. Eur Urol Focus, 2019, 5: 262-265. [22]Delgado GE, Kleber ME, Scharnagl H, et al. Serum uromodulin and mortality risk in patients undergoing coronary angiography[J]. J Am Soc Nephrol, 2017, 28: 2201-2210. [23]Steubl D, Buzkova P, Garimella PS, et al. Association of serum uromodulin with mortality and cardiovascular disease in the elderly—the Cardiovascular Health Study[J]. Nephrol Dial Transplant, 2019,74:501-509. |